NCT01255774View on ClinicalTrials.gov

Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy

PHASE3UnknownINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Age Related Macular Degeneration

Interventions

DRUG

ranibizumab

An open-label, study of intravitreally administered ranibizumab

Trial Locations (1)

10003

RECRUITING

New York Eye and Ear Infirmary, New York

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

The New York Eye & Ear Infirmary

OTHER